Navigation Links
Aware, Inc. Reports First Quarter 2009 Financial Results
Date:5/6/2009

growth of proprietary biometric systems which do not conform to industry standards; our ability to sell services contracts in a manner that is consistent with our business model; our ability to deliver service contract milestones; and our dependence on third party contractors and consultants to deliver certain services contract milestones. We refer you to the documents Aware files from time to time with the Securities and Exchange Commission, specifically the section titled Risk Factors in our annual report on Form 10-K for the fiscal year ended December 31, 2008 and other reports and filings made with the Securities and Exchange Commission.

Aware, StratiPHY, and Dr. DSL are trademarks or registered trademarks of Aware, Inc.

                                     AWARE, INC.
                       CONSOLIDATED STATEMENTS OF OPERATIONS
                       (In thousands, except per share data)
                                    (unaudited)

                                              Three Months Ended
                                                   March 31,
                                             2009           2008
    Revenue:
      Product sales                         $2,819          $3,924
      Contract revenue                       1,277           1,521
      Royalties                                477             431
        Total revenue                        4,573           5,876

    Costs and expenses:
      Cost of product sales (1)                513             824
      Cost of contract revenue (1)             908           1,018
      Research and development (1)           3,111           3,528
      Selling and marketing (1)              1,081             969
      General and administrative (1)         1,213           1,193
        Total costs and expenses             6,826           7,532

    Net loss from operations                (2,253)         (1,656)
    Inte
'/>"/>
SOURCE  Aware, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 

Related biology news :

1. Aware, Inc. Announces Final Results of Dutch Auction Tender Offer
2. Aware, Inc. Announces Q1 09 Earnings Conference Call
3. Aware, Inc. Amends and Extends Dutch Auction Tender Offer
4. Aware, Inc. Announces Preliminary Results of Dutch Auction Tender Offer
5. Aware, Inc. Amends and Extends Dutch Auction Tender Offer
6. Aware, Inc. Commences Dutch Auction Tender Offer
7. Aware, Inc. Commences Dutch Auction Tender Offer
8. Aware, Inc. Reports Fourth Quarter and 2008 Financial Results
9. Sun Microsystems and Aware, Inc. Announce Integration of Awares BioSP with Sun Identity Management Solutions
10. Aware, Inc. Reports Fourth Quarter and 2007 Financial Results
11. Aware, Inc. Announces Richard Moberg to Return as CFO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... known for a long time that some creatures evolve ... particularly for plants. But it may be that height ... University and the U. S. National Evolutionary Synthesis Center. ... May in the journal Nature Communications , Lanfear ... , Drawing from a database of global patterns in ...
(Date:5/21/2013)... considered in the management of natural resources, and ... help them recognize and respond to the relationships ... , Place-Based Conservation: Perspectives from the Social ... Northwest Research Station,s Linda Kruger, can help managers ... is published by Springer Verlag and is available ...
(Date:5/21/2013)... in the body, stem cells in the blood ... into mature immune cells that can fight off ... these cell populations, potentially leading to the development ... a team of researchers led by biologists at ... that, in mouse models, the molecule microRNA-146a (miR-146a) ...
Breaking Biology News(10 mins):Small but speedy: Short plants live in the evolutionary fast lane 2Keeping stem cells strong 2
... This release is available in Spanish . , ... of Radiology and Physical Medicine of the University ... of Public Health (Escuela Andaluza de Salud Pblica), found ... of persistent organic compound (POCs), substances internationally classified as potentially ...
... finds that a chemical found in the body is capable ... in an animal model. The hormone is gastric inhibitory polypeptide ... is a peptide hormone that is secreted in response to ... insulin as part of the digestive process in response to ...
... PITTSBURGH Practice makes perfect or at least thats ... of multiplication tables, goal kicks and piano scales ... many, to be true. Thats why neuroscientists have ... of individual synapses, or connections between neurons, increased, repetitive ...
Cached Biology News:100 percent of people carry at least 1 type of pesticide 2100 percent of people carry at least 1 type of pesticide 3Human hormone blocker found to help prevent obesity and diabetes: study 2Human hormone blocker found to help prevent obesity and diabetes: study 3Novel mechanism for long-term learning identified by Carnegie Mellon researchers 2Novel mechanism for long-term learning identified by Carnegie Mellon researchers 3
(Date:5/23/2013)... Calif. , May 23, 2013  Saddleback Memorial ... recently became the first hospital on the West ... technology. This new surgical option provides women with a ... Marc Winter , M.D., a ... and surgeon and medical director of minimally invasive surgery ...
(Date:5/23/2013)... May 23, 2013 Northwest Biotherapeutics (NASDAQ: ... DCVax ® personalized immune therapies for solid tumor ... at this year,s American Society Of Clinical Oncology (ASCO) ... its leadership role in immune therapy.  (Logo: ... meeting is the pre-eminent conference focused on clinical treatment ...
(Date:5/23/2013)... , May 23, 2013 Pusan National ... a private biotherapeutics and contract research company focused ... for cancer, announced today a publication reporting the ... with the oncolytic and immunotherapeutic vaccinia JX-594 (pexastimogene ... was published in the May 15 th , ...
(Date:5/23/2013)... Louis, Missouri (PRWEB) May 23, 2013 ... and manufacture of complete thermal systems, recently introduced ... than 90 years of experience in designing and ... complete selection of products to serve diverse customer ... options is featured at the beginning of the ...
Breaking Biology Technology:Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 2Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 2Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 3Watlow Introduces Its New Industrial Heater Catalog 2
... IBD with Novel Mode of ActionMOUNTAIN VIEW, Calif., ... announced that data from the company,s PROTECT-1 (the ... Trial) Phase II/III clinical trial of Traficet-EN(TM) (CCX282-B) ... presented in an oral session at the upcoming ...
... Technologies & Bioressources Inc. ("Neptune") (NASDAQ.NEPT - TSX.V.NTB) ... fiscal year ended February 28, 2009. Neptune reports ... three-month period ended February 28, 2009. Neptune and ... Neptune reports consolidated operating results for its nutraceutical ...
... saves time for reprint buyers by integrating the quote ... Calif., May 19 Reprints Desk, Inc., the content ... Reprints NRx for the Force.com AppExchange from salesforce.com ... the AppExchange is a procurement service that enables buyers ...
Cached Biology Technology:ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 2ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 3ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 4ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 5Neptune Technologies Reports Fiscal 2009 Results - Record revenue and profitability growth in nutraceutical business 2Neptune Technologies Reports Fiscal 2009 Results - Record revenue and profitability growth in nutraceutical business 3Neptune Technologies Reports Fiscal 2009 Results - Record revenue and profitability growth in nutraceutical business 4Neptune Technologies Reports Fiscal 2009 Results - Record revenue and profitability growth in nutraceutical business 5Reprints Desk Medical Reprint Service Now Available to Life Science Professionals on the Force.com AppExchange 2Reprints Desk Medical Reprint Service Now Available to Life Science Professionals on the Force.com AppExchange 3